Medical therapy doses at hospital discharge in patients with existing and de novo heart failure

AIMS: Uptitrating angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers (ACE‐I/ARBs), beta‐blockers, and mineralocorticoid receptor antagonists (MRAs) to optimal doses in heart failure with reduced ejection fraction (HFrEF) is associated with improved outcomes and recommended in...

Full description

Saved in:
Bibliographic Details
Published in:ESC Heart Fail
Main Authors: Diamant, Michael J., Virani, Sean A., MacKenzie, Winston J., Ignaszewski, Andrew, Toma, Mustafa, Hawkins, Nathaniel M.
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2019
Subjects:
Original Research Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6676447/
https://ncbi.nlm.nih.gov/pubmed/31218850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12454
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items